Cancer News and Research

Latest Cancer News and Research

Breath test detects lung cancer

Scientists in the United States have come up with a breath test which can detect lung cancer in patients even when it is in the early stages of the disease.

26 Feb 2007

State actions on human papillomavirus vaccine proposals

The following highlights recent news of state actions on human papillomavirus vaccine proposals. Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

25 Feb 2007

Texas Gov. Perry says Merck campaign contribution had no effect on decision to mandate Gardasil

Texas Gov. Rick Perry (R) on Thursday said that contributions made by a Merck political action committee to his campaign had no influence on his decision to issue an executive order requiring that all girls entering the sixth grade receive a human papillomavirus vaccine, the AP/International Herald Tribune reports

25 Feb 2007

CDC says Gardasil's side effects minor

CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .

25 Feb 2007

Pharmaceutical companies overcharging federal health care programs

Pharmaceutical companies have been systematically overcharging federal health care programs, costing taxpayers billions of dollars, according to federal officials, members of Congress and an advocacy group, the Newhouse News/Richmond Times-Dispatch reports.

25 Feb 2007

Alternative, diet-based method of treating brain cancer

The biologists found that KetoCal, a commercially available high-fat, low-carbohydrate diet designed to treat epilepsy in children, can significantly decrease the growth of brain tumors in laboratory mice.

22 Feb 2007

microRNA directly regulates a gene implicated in human cancers

MicroRNAs are tiny snippets of RNA that can repress activity of a gene by targeting the gene's messenger RNA (which copies DNA information and starts the process of protein production).

22 Feb 2007

Research defines the cancer role for protein Gab-2

A protein known for its ability to "bridge" interactions between other cellular proteins may spur metastasis in breast cancer, the disease's deadliest stage, a study from Burnham Institute for Medical Research has found.

22 Feb 2007

Why are African American women more likely than White women to die from breast cancer?

Why are African American women 1.5 to 2.2 times more likely than White women to die from breast cancer, despite their lower incidence of the disease? Is it solely because they have less access to medical care? Maybe not, according to a new analysis that will appear in an upcoming issue of the International Journal of Surgery.

22 Feb 2007

New understanding of how and why Taxol works in patients with breast cancer

Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.

22 Feb 2007

New way to identify which men need a second prostate biopsy

A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.

22 Feb 2007

How stem cells are regulated

Researchers from Biotech Research & Innovation Centre (BRIC) at University of Copenhagen have identified a new group of proteins that regulate the function of stem cells. The results are published in the new issue of Cell.

22 Feb 2007

Some health experts concerned proponents of mandatory HPV vaccination are acting too soon

Some public health experts recently have expressed concern that proponents of human papillomavirus vaccination legislation -- including Merck, producer of the HPV vaccine Gardasil -- have acted "far too fast" and are "potentially undermining eventual prospects for the broadest possible immunization," the New York Times reports .

22 Feb 2007

Merck pledges to stop lobbying States on Gardasil

Merck has decided to suspend its campaign to lobby for state proposals that would mandate girls receive its human papillomavirus vaccine Gardasil in light of opposition from some parents, patient advocacy groups and public health officials, the Wall Street Journal reports.

22 Feb 2007

A black and white look at breast cancer mortality

African and African American women are more likely to die of breast cancer than their white counterparts because they tend to get the disease before the menopause, suggests new research from the University of East Anglia and the Children’s Hospital Boston in collaboration with researchers in the U.S. and Italy.

21 Feb 2007

Gardasil reaction report released

The National Vaccine Information Center (NVIC) today released a new analysis of the federal Vaccine Adverse Event Reporting System (VAERS) reports of serious health problems following HPV vaccination (Merck's Gardasil) during the last six months of 2006.

21 Feb 2007

Clarient receives patent for "automated detection of objects in a biological sample"

Clarient, Inc. has announced that it has been granted a new U.S. patent related to the detection and quantification of rare tumor cells in blood and bone marrow.

21 Feb 2007

Woman awarded millions in Prempro HRT breast cancer trial

A woman in the United States has been awarded damages to the tune of $3 million after taking drug manufacturer Wyeth to court over it's postmenopausal hormone replacement therapy Prempro.

21 Feb 2007

New test identifies suitable lymphoma patients likely to respond to new therapy

Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.

20 Feb 2007

Cancer cells 100 times more likely to genetically mutate

When cells become cancerous, they also become 100 times more likely to genetically mutate than regular cells, researchers have found. The findings may explain why cells in a tumor have so many genetic mutations, but could also be bad news for cancer treatments that target a particular gene controlling cancer malignancy.

20 Feb 2007

Cancer News and Research

Latest Cancer News and Research

Breath test detects lung cancer

State actions on human papillomavirus vaccine proposals

Texas Gov. Perry says Merck campaign contribution had no effect on decision to mandate Gardasil

CDC says Gardasil's side effects minor

Pharmaceutical companies overcharging federal health care programs

Alternative, diet-based method of treating brain cancer

microRNA directly regulates a gene implicated in human cancers

Research defines the cancer role for protein Gab-2

Why are African American women more likely than White women to die from breast cancer?

New understanding of how and why Taxol works in patients with breast cancer

New way to identify which men need a second prostate biopsy

How stem cells are regulated

Some health experts concerned proponents of mandatory HPV vaccination are acting too soon

Merck pledges to stop lobbying States on Gardasil

A black and white look at breast cancer mortality

Gardasil reaction report released

Clarient receives patent for "automated detection of objects in a biological sample"

Woman awarded millions in Prempro HRT breast cancer trial

New test identifies suitable lymphoma patients likely to respond to new therapy

Cancer cells 100 times more likely to genetically mutate

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in